載入...
SRC Promotes Tamoxifen Resistance in Breast Cancer via Up-Regulating SIRT1
BACKGROUND: Endocrine therapy plays a key role in estrogen receptor-positive breast cancer patients; but, tamoxifen resistance could be a real difficulty for these patients. Several attempts have been made to explore the mechanism and new therapies for these patients. We intend to clarify the expr...
Na minha lista:
| 發表在: | Onco Targets Ther |
|---|---|
| Main Authors: | , , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
Dove
2020
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7259490/ https://ncbi.nlm.nih.gov/pubmed/32547094 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/OTT.S245749 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|